Table 1.

Survival after C₂ hemisection (SH) across experimental groups

Experimental Group	n	Survival n (%)
SH (+ aCSF)	17	14 (82)
SH + BDNF	18	15 (83)
SH + TrkB-Fc	14	7 (50)
SH + non-sense siRNA	10	9 (90)
SH + TrkB siRNA	12	9 (75)

Data presented are the initial number of animals (n) and the number (and percent) that survived in each group at the terminal experiment. The SH 14D group was not different than aCSF treated SH at SH 7D, so these were grouped. There were no statistically significant differences between the treatment groups in pair-wise analyses. Note that six animals in the BDNF treated SH group and eight animals in the aCSF treated SH group had terminal experiments at SH 7D, and the rest of the animals were terminal at SH 14D.